nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP3A4—Everolimus—kidney cancer	0.121	0.26	CbGbCtD
Pentobarbital—CYP3A4—Temsirolimus—kidney cancer	0.0817	0.176	CbGbCtD
Pentobarbital—CYP2C19—Sorafenib—kidney cancer	0.0515	0.111	CbGbCtD
Pentobarbital—CYP3A4—Pazopanib—kidney cancer	0.0429	0.0924	CbGbCtD
Pentobarbital—CYP3A4—Erlotinib—kidney cancer	0.0306	0.0659	CbGbCtD
Pentobarbital—CYP3A4—Paclitaxel—kidney cancer	0.028	0.0603	CbGbCtD
Pentobarbital—CYP3A4—Sorafenib—kidney cancer	0.0249	0.0536	CbGbCtD
Pentobarbital—CYP3A4—Vinblastine—kidney cancer	0.0246	0.0529	CbGbCtD
Pentobarbital—CYP3A4—Vincristine—kidney cancer	0.0242	0.052	CbGbCtD
Pentobarbital—CYP3A4—Sunitinib—kidney cancer	0.0202	0.0434	CbGbCtD
Pentobarbital—CYP3A4—Doxorubicin—kidney cancer	0.0151	0.0325	CbGbCtD
Pentobarbital—Hypoxia—Gemcitabine—kidney cancer	0.00701	0.0195	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Temsirolimus—kidney cancer	0.00687	0.0191	CcSEcCtD
Pentobarbital—Hepatocellular injury—Everolimus—kidney cancer	0.00664	0.0185	CcSEcCtD
Pentobarbital—Hepatocellular injury—Erlotinib—kidney cancer	0.00641	0.0178	CcSEcCtD
Pentobarbital—Respiratory failure—Sunitinib—kidney cancer	0.00565	0.0157	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Sunitinib—kidney cancer	0.00536	0.0149	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Everolimus—kidney cancer	0.00511	0.0142	CcSEcCtD
Pentobarbital—Respiratory failure—Vincristine—kidney cancer	0.00478	0.0133	CcSEcCtD
Pentobarbital—Respiratory failure—Gemcitabine—kidney cancer	0.00453	0.0126	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Sorafenib—kidney cancer	0.00443	0.0123	CcSEcCtD
Pentobarbital—Injection site reaction—Gemcitabine—kidney cancer	0.00442	0.0123	CcSEcCtD
Pentobarbital—Bradycardia—Pazopanib—kidney cancer	0.0043	0.012	CcSEcCtD
Pentobarbital—Respiratory failure—Paclitaxel—kidney cancer	0.00379	0.0106	CcSEcCtD
Pentobarbital—Injection site reaction—Paclitaxel—kidney cancer	0.0037	0.0103	CcSEcCtD
Pentobarbital—Angioedema—Temsirolimus—kidney cancer	0.00357	0.00992	CcSEcCtD
Pentobarbital—Hallucination—Everolimus—kidney cancer	0.00332	0.00923	CcSEcCtD
Pentobarbital—Anxiety—Temsirolimus—kidney cancer	0.00331	0.00921	CcSEcCtD
Pentobarbital—Syncope—Pazopanib—kidney cancer	0.0033	0.00917	CcSEcCtD
Pentobarbital—Loss of consciousness—Pazopanib—kidney cancer	0.00323	0.00899	CcSEcCtD
Pentobarbital—Ataxia—Vincristine—kidney cancer	0.0032	0.00891	CcSEcCtD
Pentobarbital—Injection site reaction—Capecitabine—kidney cancer	0.00304	0.00846	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Capecitabine—kidney cancer	0.00295	0.00821	CcSEcCtD
Pentobarbital—Shock—Pazopanib—kidney cancer	0.00295	0.00821	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.00287	0.00797	CcSEcCtD
Pentobarbital—Bradycardia—Sunitinib—kidney cancer	0.00284	0.00789	CcSEcCtD
Pentobarbital—Somnolence—Temsirolimus—kidney cancer	0.00283	0.00788	CcSEcCtD
Pentobarbital—Constipation—Temsirolimus—kidney cancer	0.00272	0.00758	CcSEcCtD
Pentobarbital—Agitation—Everolimus—kidney cancer	0.00267	0.00742	CcSEcCtD
Pentobarbital—Somnolence—Pazopanib—kidney cancer	0.00267	0.00742	CcSEcCtD
Pentobarbital—Angioedema—Everolimus—kidney cancer	0.00265	0.00738	CcSEcCtD
Pentobarbital—Syncope—Everolimus—kidney cancer	0.0026	0.00724	CcSEcCtD
Pentobarbital—Loss of consciousness—Everolimus—kidney cancer	0.00255	0.0071	CcSEcCtD
Pentobarbital—Ataxia—Paclitaxel—kidney cancer	0.00254	0.00707	CcSEcCtD
Pentobarbital—Body temperature increased—Temsirolimus—kidney cancer	0.00252	0.007	CcSEcCtD
Pentobarbital—Syncope—Erlotinib—kidney cancer	0.00251	0.00699	CcSEcCtD
Pentobarbital—Anxiety—Everolimus—kidney cancer	0.00246	0.00685	CcSEcCtD
Pentobarbital—Loss of consciousness—Erlotinib—kidney cancer	0.00246	0.00685	CcSEcCtD
Pentobarbital—Anxiety—Erlotinib—kidney cancer	0.00238	0.00661	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00235	0.00654	CcSEcCtD
Pentobarbital—Hypersensitivity—Temsirolimus—kidney cancer	0.00235	0.00653	CcSEcCtD
Pentobarbital—Hallucination—Vincristine—kidney cancer	0.00234	0.00652	CcSEcCtD
Pentobarbital—Liver injury—Doxorubicin—kidney cancer	0.00234	0.00652	CcSEcCtD
Pentobarbital—Shock—Everolimus—kidney cancer	0.00233	0.00648	CcSEcCtD
Pentobarbital—Angioedema—Sorafenib—kidney cancer	0.0023	0.0064	CcSEcCtD
Pentobarbital—Syncope—Sorafenib—kidney cancer	0.00226	0.00629	CcSEcCtD
Pentobarbital—Shock—Erlotinib—kidney cancer	0.00225	0.00626	CcSEcCtD
Pentobarbital—Angioedema—Sunitinib—kidney cancer	0.00222	0.00616	CcSEcCtD
Pentobarbital—Loss of consciousness—Sorafenib—kidney cancer	0.00221	0.00616	CcSEcCtD
Pentobarbital—Hypotension—Everolimus—kidney cancer	0.00221	0.00616	CcSEcCtD
Pentobarbital—Somnolence—Everolimus—kidney cancer	0.00211	0.00586	CcSEcCtD
Pentobarbital—Dizziness—Temsirolimus—kidney cancer	0.00211	0.00586	CcSEcCtD
Pentobarbital—Ataxia—Capecitabine—kidney cancer	0.00209	0.00581	CcSEcCtD
Pentobarbital—Constipation—Vinblastine—kidney cancer	0.00203	0.00566	CcSEcCtD
Pentobarbital—Constipation—Everolimus—kidney cancer	0.00203	0.00564	CcSEcCtD
Pentobarbital—Vomiting—Temsirolimus—kidney cancer	0.00202	0.00563	CcSEcCtD
Pentobarbital—Shock—Sorafenib—kidney cancer	0.00202	0.00563	CcSEcCtD
Pentobarbital—Rash—Temsirolimus—kidney cancer	0.00201	0.00559	CcSEcCtD
Pentobarbital—Dermatitis—Temsirolimus—kidney cancer	0.00201	0.00558	CcSEcCtD
Pentobarbital—Headache—Temsirolimus—kidney cancer	0.002	0.00555	CcSEcCtD
Pentobarbital—Dizziness—Pazopanib—kidney cancer	0.00198	0.00552	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—kidney cancer	0.00197	0.00548	CcSEcCtD
Pentobarbital—Feeling abnormal—Vinblastine—kidney cancer	0.00196	0.00545	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—kidney cancer	0.00196	0.00545	CcSEcCtD
Pentobarbital—Constipation—Erlotinib—kidney cancer	0.00195	0.00544	CcSEcCtD
Pentobarbital—Feeling abnormal—Everolimus—kidney cancer	0.00195	0.00543	CcSEcCtD
Pentobarbital—Shock—Sunitinib—kidney cancer	0.00195	0.00542	CcSEcCtD
Pentobarbital—Vomiting—Pazopanib—kidney cancer	0.00191	0.00531	CcSEcCtD
Pentobarbital—Bradycardia—Paclitaxel—kidney cancer	0.0019	0.0053	CcSEcCtD
Pentobarbital—Rash—Pazopanib—kidney cancer	0.00189	0.00526	CcSEcCtD
Pentobarbital—Nausea—Temsirolimus—kidney cancer	0.00189	0.00526	CcSEcCtD
Pentobarbital—Dermatitis—Pazopanib—kidney cancer	0.00189	0.00526	CcSEcCtD
Pentobarbital—Agitation—Vincristine—kidney cancer	0.00188	0.00524	CcSEcCtD
Pentobarbital—Headache—Pazopanib—kidney cancer	0.00188	0.00523	CcSEcCtD
Pentobarbital—Body temperature increased—Everolimus—kidney cancer	0.00187	0.00521	CcSEcCtD
Pentobarbital—Body temperature increased—Erlotinib—kidney cancer	0.00181	0.00503	CcSEcCtD
Pentobarbital—Nausea—Pazopanib—kidney cancer	0.00178	0.00496	CcSEcCtD
Pentobarbital—Constipation—Sorafenib—kidney cancer	0.00176	0.00489	CcSEcCtD
Pentobarbital—Hypersensitivity—Vinblastine—kidney cancer	0.00175	0.00487	CcSEcCtD
Pentobarbital—Hypersensitivity—Everolimus—kidney cancer	0.00175	0.00486	CcSEcCtD
Pentobarbital—Constipation—Sunitinib—kidney cancer	0.00169	0.00471	CcSEcCtD
Pentobarbital—Body temperature increased—Sorafenib—kidney cancer	0.00163	0.00452	CcSEcCtD
Pentobarbital—Tension—Paclitaxel—kidney cancer	0.0016	0.00445	CcSEcCtD
Pentobarbital—Nervousness—Paclitaxel—kidney cancer	0.00158	0.0044	CcSEcCtD
Pentobarbital—Dizziness—Vinblastine—kidney cancer	0.00157	0.00437	CcSEcCtD
Pentobarbital—Dizziness—Everolimus—kidney cancer	0.00157	0.00436	CcSEcCtD
Pentobarbital—Body temperature increased—Sunitinib—kidney cancer	0.00156	0.00435	CcSEcCtD
Pentobarbital—Hypotension—Vincristine—kidney cancer	0.00156	0.00435	CcSEcCtD
Pentobarbital—Bradycardia—Capecitabine—kidney cancer	0.00156	0.00435	CcSEcCtD
Pentobarbital—Feeling abnormal—Dactinomycin—kidney cancer	0.00154	0.00429	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00152	0.00422	CcSEcCtD
Pentobarbital—Hypersensitivity—Sorafenib—kidney cancer	0.00152	0.00421	CcSEcCtD
Pentobarbital—Vomiting—Vinblastine—kidney cancer	0.00151	0.00421	CcSEcCtD
Pentobarbital—Dizziness—Erlotinib—kidney cancer	0.00151	0.0042	CcSEcCtD
Pentobarbital—Vomiting—Everolimus—kidney cancer	0.00151	0.00419	CcSEcCtD
Pentobarbital—Agitation—Paclitaxel—kidney cancer	0.0015	0.00416	CcSEcCtD
Pentobarbital—Rash—Everolimus—kidney cancer	0.00149	0.00416	CcSEcCtD
Pentobarbital—Dermatitis—Everolimus—kidney cancer	0.00149	0.00415	CcSEcCtD
Pentobarbital—Headache—Vinblastine—kidney cancer	0.00149	0.00414	CcSEcCtD
Pentobarbital—Angioedema—Paclitaxel—kidney cancer	0.00149	0.00414	CcSEcCtD
Pentobarbital—Headache—Everolimus—kidney cancer	0.00148	0.00413	CcSEcCtD
Pentobarbital—Hypotension—Gemcitabine—kidney cancer	0.00148	0.00413	CcSEcCtD
Pentobarbital—Body temperature increased—Dactinomycin—kidney cancer	0.00148	0.00412	CcSEcCtD
Pentobarbital—Syncope—Paclitaxel—kidney cancer	0.00146	0.00406	CcSEcCtD
Pentobarbital—Hypersensitivity—Sunitinib—kidney cancer	0.00146	0.00406	CcSEcCtD
Pentobarbital—Vomiting—Erlotinib—kidney cancer	0.00145	0.00404	CcSEcCtD
Pentobarbital—Rash—Erlotinib—kidney cancer	0.00144	0.00401	CcSEcCtD
Pentobarbital—Dermatitis—Erlotinib—kidney cancer	0.00144	0.00401	CcSEcCtD
Pentobarbital—Headache—Erlotinib—kidney cancer	0.00143	0.00398	CcSEcCtD
Pentobarbital—Loss of consciousness—Paclitaxel—kidney cancer	0.00143	0.00398	CcSEcCtD
Pentobarbital—Constipation—Vincristine—kidney cancer	0.00143	0.00398	CcSEcCtD
Pentobarbital—Nausea—Vinblastine—kidney cancer	0.00141	0.00393	CcSEcCtD
Pentobarbital—Somnolence—Gemcitabine—kidney cancer	0.00141	0.00393	CcSEcCtD
Pentobarbital—Nausea—Everolimus—kidney cancer	0.00141	0.00391	CcSEcCtD
Pentobarbital—Anxiety—Paclitaxel—kidney cancer	0.00138	0.00384	CcSEcCtD
Pentobarbital—Hypersensitivity—Dactinomycin—kidney cancer	0.00138	0.00384	CcSEcCtD
Pentobarbital—Dizziness—Sorafenib—kidney cancer	0.00136	0.00378	CcSEcCtD
Pentobarbital—Constipation—Gemcitabine—kidney cancer	0.00136	0.00378	CcSEcCtD
Pentobarbital—Nausea—Erlotinib—kidney cancer	0.00136	0.00378	CcSEcCtD
Pentobarbital—Ataxia—Doxorubicin—kidney cancer	0.00135	0.00374	CcSEcCtD
Pentobarbital—Confusional state—Paclitaxel—kidney cancer	0.00134	0.00373	CcSEcCtD
Pentobarbital—Body temperature increased—Vincristine—kidney cancer	0.00132	0.00368	CcSEcCtD
Pentobarbital—Dizziness—Sunitinib—kidney cancer	0.00131	0.00364	CcSEcCtD
Pentobarbital—Feeling abnormal—Gemcitabine—kidney cancer	0.00131	0.00364	CcSEcCtD
Pentobarbital—Shock—Paclitaxel—kidney cancer	0.00131	0.00364	CcSEcCtD
Pentobarbital—Vomiting—Sorafenib—kidney cancer	0.00131	0.00364	CcSEcCtD
Pentobarbital—Rash—Sorafenib—kidney cancer	0.0013	0.00361	CcSEcCtD
Pentobarbital—Dermatitis—Sorafenib—kidney cancer	0.0013	0.0036	CcSEcCtD
Pentobarbital—Headache—Sorafenib—kidney cancer	0.00129	0.00358	CcSEcCtD
Pentobarbital—Vomiting—Sunitinib—kidney cancer	0.00126	0.0035	CcSEcCtD
Pentobarbital—Body temperature increased—Gemcitabine—kidney cancer	0.00126	0.00349	CcSEcCtD
Pentobarbital—Rash—Sunitinib—kidney cancer	0.00125	0.00347	CcSEcCtD
Pentobarbital—Dermatitis—Sunitinib—kidney cancer	0.00125	0.00347	CcSEcCtD
Pentobarbital—Hypotension—Paclitaxel—kidney cancer	0.00124	0.00346	CcSEcCtD
Pentobarbital—Headache—Sunitinib—kidney cancer	0.00124	0.00345	CcSEcCtD
Pentobarbital—Hypersensitivity—Vincristine—kidney cancer	0.00123	0.00343	CcSEcCtD
Pentobarbital—Nausea—Sorafenib—kidney cancer	0.00122	0.0034	CcSEcCtD
Pentobarbital—Syncope—Capecitabine—kidney cancer	0.0012	0.00333	CcSEcCtD
Pentobarbital—Vomiting—Dactinomycin—kidney cancer	0.00119	0.00331	CcSEcCtD
Pentobarbital—Somnolence—Paclitaxel—kidney cancer	0.00118	0.00329	CcSEcCtD
Pentobarbital—Rash—Dactinomycin—kidney cancer	0.00118	0.00329	CcSEcCtD
Pentobarbital—Nausea—Sunitinib—kidney cancer	0.00118	0.00327	CcSEcCtD
Pentobarbital—Loss of consciousness—Capecitabine—kidney cancer	0.00117	0.00327	CcSEcCtD
Pentobarbital—Constipation—Paclitaxel—kidney cancer	0.00114	0.00316	CcSEcCtD
Pentobarbital—Anxiety—Capecitabine—kidney cancer	0.00113	0.00315	CcSEcCtD
Pentobarbital—Nausea—Dactinomycin—kidney cancer	0.00111	0.0031	CcSEcCtD
Pentobarbital—Dizziness—Vincristine—kidney cancer	0.00111	0.00308	CcSEcCtD
Pentobarbital—Confusional state—Capecitabine—kidney cancer	0.0011	0.00306	CcSEcCtD
Pentobarbital—Feeling abnormal—Paclitaxel—kidney cancer	0.0011	0.00305	CcSEcCtD
Pentobarbital—Shock—Capecitabine—kidney cancer	0.00107	0.00299	CcSEcCtD
Pentobarbital—Vomiting—Vincristine—kidney cancer	0.00106	0.00296	CcSEcCtD
Pentobarbital—Rash—Vincristine—kidney cancer	0.00106	0.00294	CcSEcCtD
Pentobarbital—Dermatitis—Vincristine—kidney cancer	0.00105	0.00293	CcSEcCtD
Pentobarbital—Body temperature increased—Paclitaxel—kidney cancer	0.00105	0.00292	CcSEcCtD
Pentobarbital—Headache—Vincristine—kidney cancer	0.00105	0.00292	CcSEcCtD
Pentobarbital—Hypotension—Capecitabine—kidney cancer	0.00102	0.00284	CcSEcCtD
Pentobarbital—Vomiting—Gemcitabine—kidney cancer	0.00101	0.00281	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—kidney cancer	0.00101	0.0028	CcSEcCtD
Pentobarbital—Rash—Gemcitabine—kidney cancer	0.001	0.00278	CcSEcCtD
Pentobarbital—Dermatitis—Gemcitabine—kidney cancer	0.001	0.00278	CcSEcCtD
Pentobarbital—Headache—Gemcitabine—kidney cancer	0.000995	0.00277	CcSEcCtD
Pentobarbital—Nausea—Vincristine—kidney cancer	0.000994	0.00277	CcSEcCtD
Pentobarbital—Hypersensitivity—Paclitaxel—kidney cancer	0.000979	0.00272	CcSEcCtD
Pentobarbital—Nausea—Gemcitabine—kidney cancer	0.000943	0.00262	CcSEcCtD
Pentobarbital—Constipation—Capecitabine—kidney cancer	0.000933	0.0026	CcSEcCtD
Pentobarbital—Feeling abnormal—Capecitabine—kidney cancer	0.000899	0.0025	CcSEcCtD
Pentobarbital—Dizziness—Paclitaxel—kidney cancer	0.000879	0.00245	CcSEcCtD
Pentobarbital—Body temperature increased—Capecitabine—kidney cancer	0.000862	0.0024	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—kidney cancer	0.000846	0.00235	CcSEcCtD
Pentobarbital—Vomiting—Paclitaxel—kidney cancer	0.000845	0.00235	CcSEcCtD
Pentobarbital—Rash—Paclitaxel—kidney cancer	0.000838	0.00233	CcSEcCtD
Pentobarbital—Dermatitis—Paclitaxel—kidney cancer	0.000837	0.00233	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—kidney cancer	0.000837	0.00233	CcSEcCtD
Pentobarbital—Headache—Paclitaxel—kidney cancer	0.000833	0.00232	CcSEcCtD
Pentobarbital—Hypersensitivity—Capecitabine—kidney cancer	0.000804	0.00224	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—kidney cancer	0.000792	0.0022	CcSEcCtD
Pentobarbital—Nausea—Paclitaxel—kidney cancer	0.00079	0.0022	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—kidney cancer	0.000773	0.00215	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—kidney cancer	0.000757	0.00211	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—kidney cancer	0.000731	0.00203	CcSEcCtD
Pentobarbital—Dizziness—Capecitabine—kidney cancer	0.000721	0.00201	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—kidney cancer	0.000709	0.00197	CcSEcCtD
Pentobarbital—Vomiting—Capecitabine—kidney cancer	0.000694	0.00193	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—kidney cancer	0.000692	0.00192	CcSEcCtD
Pentobarbital—Rash—Capecitabine—kidney cancer	0.000688	0.00191	CcSEcCtD
Pentobarbital—Dermatitis—Capecitabine—kidney cancer	0.000687	0.00191	CcSEcCtD
Pentobarbital—Headache—Capecitabine—kidney cancer	0.000683	0.0019	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—kidney cancer	0.000657	0.00183	CcSEcCtD
Pentobarbital—Nausea—Capecitabine—kidney cancer	0.000648	0.0018	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—kidney cancer	0.000625	0.00174	CcSEcCtD
Pentobarbital—Constipation—Doxorubicin—kidney cancer	0.000601	0.00167	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—kidney cancer	0.000579	0.00161	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—kidney cancer	0.000556	0.00155	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—kidney cancer	0.000518	0.00144	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—kidney cancer	0.000465	0.00129	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—kidney cancer	0.000447	0.00124	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—kidney cancer	0.000443	0.00123	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—kidney cancer	0.000443	0.00123	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—kidney cancer	0.000441	0.00123	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—kidney cancer	0.000418	0.00116	CcSEcCtD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000178	0.00101	CbGpPWpGaD
Pentobarbital—GABRA2—Ion channel transport—RAF1—kidney cancer	0.000177	0.001	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000176	0.001	CbGpPWpGaD
Pentobarbital—GABRB3—Ion channel transport—RAF1—kidney cancer	0.000176	0.000997	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000174	0.000991	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000174	0.000989	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ACY1—kidney cancer	0.000173	0.000984	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000173	0.000983	CbGpPWpGaD
Pentobarbital—GABRG2—Ion channel transport—RAF1—kidney cancer	0.000172	0.000979	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000169	0.000962	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000168	0.000958	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000168	0.000957	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—JUN—kidney cancer	0.000168	0.000956	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000168	0.000953	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—CTNNB1—kidney cancer	0.000167	0.000949	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000166	0.000945	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000165	0.00094	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000164	0.000934	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000163	0.000924	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—RAF1—kidney cancer	0.000162	0.000923	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—BRAF—kidney cancer	0.000162	0.000919	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000161	0.000914	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000161	0.000912	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—BRAF—kidney cancer	0.00016	0.000908	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000159	0.000905	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000159	0.000903	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—RAF1—kidney cancer	0.000158	0.000895	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000155	0.000879	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000152	0.000866	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000152	0.000864	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000152	0.000863	CbGpPWpGaD
Pentobarbital—GABRA1—Ion channel transport—RAF1—kidney cancer	0.000151	0.000856	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000149	0.000848	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000148	0.000843	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000148	0.000839	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PDHB—kidney cancer	0.000147	0.000837	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000147	0.000834	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—POMC—kidney cancer	0.000147	0.000834	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—BRAF—kidney cancer	0.000146	0.00083	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—MAPK1—kidney cancer	0.000146	0.000828	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000146	0.000828	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000145	0.000826	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000145	0.000826	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000145	0.000824	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000143	0.000811	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000143	0.00081	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—BRAF—kidney cancer	0.000142	0.000807	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000142	0.000805	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000141	0.000802	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000141	0.000801	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00014	0.000796	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—BRAF—kidney cancer	0.000139	0.000792	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000139	0.00079	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MAPK3—kidney cancer	0.000139	0.00079	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000139	0.000788	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CCBL1—kidney cancer	0.000138	0.000787	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTP1—kidney cancer	0.000138	0.000783	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000138	0.000782	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—BRAF—kidney cancer	0.000137	0.000778	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000137	0.000777	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000136	0.000774	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—BRAF—kidney cancer	0.000136	0.000773	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	0.000136	0.000772	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000136	0.000772	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000135	0.00077	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000135	0.000769	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—RAF1—kidney cancer	0.000135	0.000768	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000134	0.000764	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000134	0.000763	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—BRAF—kidney cancer	0.000134	0.000759	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—RAF1—kidney cancer	0.000133	0.000758	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000133	0.000755	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—MAPK1—kidney cancer	0.000133	0.000753	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MAPK1—kidney cancer	0.000132	0.000752	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000128	0.00073	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000127	0.000723	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000127	0.00072	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTM1—kidney cancer	0.000127	0.00072	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000125	0.00071	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	0.000125	0.00071	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—RAF1—kidney cancer	0.000122	0.000693	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000122	0.000691	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000121	0.000687	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GLIPR1—kidney cancer	0.00012	0.000682	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPAT—kidney cancer	0.00012	0.000682	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	0.00012	0.000682	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTT1—kidney cancer	0.00012	0.000679	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000119	0.000679	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—RAF1—kidney cancer	0.000119	0.000673	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	0.000118	0.000673	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000118	0.000672	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000117	0.000667	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—BRAF—kidney cancer	0.000117	0.000664	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—RAF1—kidney cancer	0.000116	0.000661	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000116	0.00066	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000116	0.000659	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—RAF1—kidney cancer	0.000114	0.00065	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—RAF1—kidney cancer	0.000114	0.000646	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000113	0.00064	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—PTGS1—kidney cancer	0.000112	0.000637	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—FH—kidney cancer	0.000112	0.000634	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APRT—kidney cancer	0.000112	0.000634	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—RAF1—kidney cancer	0.000112	0.000634	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—MAPK1—kidney cancer	0.000111	0.000633	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000111	0.000629	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000109	0.000621	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000109	0.000618	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—MAPK1—kidney cancer	0.000108	0.000614	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000108	0.000614	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000106	0.000603	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000106	0.000603	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACY1—kidney cancer	0.000106	0.0006	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPC3—kidney cancer	0.000105	0.000596	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000104	0.000592	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000102	0.000582	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CA2—kidney cancer	0.000102	0.00058	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000102	0.000578	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000101	0.000576	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.99e-05	0.000568	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALAD—kidney cancer	9.95e-05	0.000565	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—RAF1—kidney cancer	9.75e-05	0.000554	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ST3GAL2—kidney cancer	9.71e-05	0.000552	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALDH1A1—kidney cancer	9.49e-05	0.000539	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	9.27e-05	0.000527	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—MAPK1—kidney cancer	9.27e-05	0.000527	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—MAPK1—kidney cancer	9.15e-05	0.00052	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC5A3—kidney cancer	9.1e-05	0.000517	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PGK1—kidney cancer	9.1e-05	0.000517	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	9e-05	0.000512	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PDHB—kidney cancer	8.98e-05	0.00051	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—POMC—kidney cancer	8.95e-05	0.000509	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LDHB—kidney cancer	8.92e-05	0.000507	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	8.73e-05	0.000496	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CCBL1—kidney cancer	8.44e-05	0.00048	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—MAPK1—kidney cancer	8.37e-05	0.000475	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTP1—kidney cancer	8.29e-05	0.000471	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	8.17e-05	0.000464	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—MAPK1—kidney cancer	8.13e-05	0.000462	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—MAPK1—kidney cancer	7.98e-05	0.000454	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—MAPK1—kidney cancer	7.84e-05	0.000446	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—MAPK1—kidney cancer	7.79e-05	0.000443	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CA9—kidney cancer	7.74e-05	0.00044	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—MAPK1—kidney cancer	7.65e-05	0.000435	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.63e-05	0.000434	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—kidney cancer	7.61e-05	0.000433	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	7.51e-05	0.000427	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GLIPR1—kidney cancer	7.32e-05	0.000416	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPAT—kidney cancer	7.32e-05	0.000416	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	7.26e-05	0.000413	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.23e-05	0.000411	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	7.22e-05	0.00041	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	7.17e-05	0.000408	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.15e-05	0.000407	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	7.12e-05	0.000405	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FH—kidney cancer	6.8e-05	0.000387	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APRT—kidney cancer	6.8e-05	0.000387	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—MAPK1—kidney cancer	6.69e-05	0.00038	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.65e-05	0.000378	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CRABP1—kidney cancer	6.58e-05	0.000374	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	6.56e-05	0.000373	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPC3—kidney cancer	6.4e-05	0.000364	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	6.37e-05	0.000362	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACY1—kidney cancer	6.35e-05	0.000361	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	6.26e-05	0.000356	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA2—kidney cancer	6.22e-05	0.000354	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	6.15e-05	0.000349	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ITPR2—kidney cancer	6.11e-05	0.000348	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	6.11e-05	0.000347	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALAD—kidney cancer	6.06e-05	0.000345	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	6e-05	0.000341	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ST3GAL2—kidney cancer	5.92e-05	0.000336	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALDH1A1—kidney cancer	5.79e-05	0.000329	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ACHE—kidney cancer	5.58e-05	0.000317	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—kidney cancer	5.58e-05	0.000317	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PGK1—kidney cancer	5.55e-05	0.000315	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A3—kidney cancer	5.55e-05	0.000315	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LDHB—kidney cancer	5.44e-05	0.000309	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PDHB—kidney cancer	5.4e-05	0.000307	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—POMC—kidney cancer	5.38e-05	0.000306	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SCARB1—kidney cancer	5.28e-05	0.0003	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.24e-05	0.000298	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS1—kidney cancer	5.23e-05	0.000297	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PSMD7—kidney cancer	5.12e-05	0.000291	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CCBL1—kidney cancer	5.08e-05	0.000288	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—BCHE—kidney cancer	4.86e-05	0.000276	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC5A5—kidney cancer	4.8e-05	0.000273	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA9—kidney cancer	4.72e-05	0.000268	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC2A1—kidney cancer	4.63e-05	0.000263	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.61e-05	0.000262	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPAT—kidney cancer	4.4e-05	0.00025	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.4e-05	0.00025	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FH—kidney cancer	4.09e-05	0.000233	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APRT—kidney cancer	4.09e-05	0.000233	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CRABP1—kidney cancer	4.01e-05	0.000228	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—kidney cancer	3.87e-05	0.00022	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPC3—kidney cancer	3.85e-05	0.000219	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA2—kidney cancer	3.74e-05	0.000213	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ITPR2—kidney cancer	3.73e-05	0.000212	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCB1—kidney cancer	3.66e-05	0.000208	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALAD—kidney cancer	3.65e-05	0.000207	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.56e-05	0.000202	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—kidney cancer	3.55e-05	0.000202	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.48e-05	0.000198	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.44e-05	0.000195	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACHE—kidney cancer	3.4e-05	0.000193	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—kidney cancer	3.4e-05	0.000193	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1A1—kidney cancer	3.37e-05	0.000191	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PGK1—kidney cancer	3.34e-05	0.00019	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.34e-05	0.00019	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LDHB—kidney cancer	3.27e-05	0.000186	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SCARB1—kidney cancer	3.22e-05	0.000183	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS1—kidney cancer	3.19e-05	0.000181	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PSMD7—kidney cancer	3.12e-05	0.000178	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—BCHE—kidney cancer	2.96e-05	0.000168	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.93e-05	0.000166	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA9—kidney cancer	2.84e-05	0.000161	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.83e-05	0.000161	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.74e-05	0.000156	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—POMC—kidney cancer	2.51e-05	0.000143	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CRABP1—kidney cancer	2.41e-05	0.000137	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.39e-05	0.000136	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—kidney cancer	2.36e-05	0.000134	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ITPR2—kidney cancer	2.24e-05	0.000127	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCB1—kidney cancer	2.23e-05	0.000127	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—kidney cancer	2.17e-05	0.000123	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.05e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—kidney cancer	2.04e-05	0.000116	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACHE—kidney cancer	2.04e-05	0.000116	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—kidney cancer	2e-05	0.000114	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SCARB1—kidney cancer	1.94e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS1—kidney cancer	1.92e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PSMD7—kidney cancer	1.88e-05	0.000107	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—BCHE—kidney cancer	1.78e-05	0.000101	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.76e-05	0.0001	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTEN—kidney cancer	1.75e-05	9.92e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.7e-05	9.66e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.69e-05	9.58e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—POMC—kidney cancer	1.53e-05	8.7e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—kidney cancer	1.42e-05	8.05e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCB1—kidney cancer	1.34e-05	7.62e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—kidney cancer	1.3e-05	7.4e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.23e-05	7.02e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.23e-05	7e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—kidney cancer	1.22e-05	6.94e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTEN—kidney cancer	1.06e-05	6.05e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—POMC—kidney cancer	9.2e-06	5.23e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.51e-06	4.27e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—kidney cancer	7.34e-06	4.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTEN—kidney cancer	6.4e-06	3.64e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.52e-06	2.57e-05	CbGpPWpGaD
